In an exclusive interview, Stephen Ubl, President and CEO of the Pharmaceutical Researchers and Manufacturers of America (PhRMA), the association representing the leading innovative biopharmaceutical companies in the USA, discusses the onset of a new “golden era” in medicine. He goes on to discuss pricing issues, engaging in a constructive dialogue with the current administration, and building a stronger brand image for the pharmaceutical industry at large.
We are really starting to witness the advent of personalized therapies and smart missions in which there is a real convergence underway between diagnostic technologies and drug device combinations. We can genuinely talk about the onset of a new “golden era” of medicine
